A drug shortage is a quality failure with a body count.
Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.
By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.
The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.
| Drug | Company | Therapeutic area | Availability | Status | Posted |
|---|---|---|---|---|---|
| Clonazepam TabletTablet | Rubicon Research Private Limited | Neurology | Available | Current | 2023-03-10 |
| Carboplatin InjectionInjection | Teyro Labs | Oncology | — | To Be Discontinued | 2026-06-01 |
| Clonazepam TabletTablet | Rubicon Research Private Limited | Neurology | Available | Current | 2023-03-10 |
| Triamcinolone Hexacetonide InjectionInjection | Medexus | Rheumatology | Unavailable | Current | 2021-05-04 |
| Dehydrated Alcohol Injection, SolutionInjection | Accord Healthcare Inc. | Cardiovascular | — | To Be Discontinued | 2026-05-27 |
| Iron Sucrose InjectionInjection | Mylan Institutional, a Viatris Company | Hematology | — | To Be Discontinued | 2026-05-21 |
| Gadoterate Meglumine InjectionInjection | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Medical Imaging | — | To Be Discontinued | 2026-05-21 |
| Alteplase InjectionInjection | Genentech, Inc | Cardiovascular | — | To Be Discontinued | 2026-05-21 |
| Ketorolac Tromethamine InjectionInjection | Alembic Pharmaceuticals | Analgesia/Addiction | Available | Current | 2018-03-23 |
| Lidocaine Hydrochloride InjectionInjection | Spectra Medical Devices, LLC | Anesthesia | Unavailable | Current | 2018-06-14 |
| Ketorolac Tromethamine InjectionInjection | Alembic Pharmaceuticals | Analgesia/Addiction | Available | Current | 2018-03-23 |
| Activated Charcoal Oral SuspensionOral Suspension | Padagis US LLC | Other | — | To Be Discontinued | 2026-05-15 |
| Ketorolac Tromethamine InjectionInjection | Alembic Pharmaceuticals | Analgesia/Addiction | Available | Current | 2018-03-23 |
| Activated Charcoal Oral SuspensionOral Suspension | Padagis US LLC | Other | — | To Be Discontinued | 2026-05-15 |
| Liraglutide InjectionInjection | Teva Pharmaceuticals USA, Inc. | Endocrinology/Metabolism | — | To Be Discontinued | 2026-05-14 |
| Lisdexamfetamine Dimesylate CapsuleCapsule | Hikma Pharmaceuticals USA, Inc. | Psychiatry | Limited | Current | 2023-07-14 |
| Dobutamine Hydrochloride InjectionInjection | Hainan Poly Pharm. Co., Ltd. | Cardiovascular | Available | Current | 2017-11-06 |
| Sulconazole Nitrate SolutionSolution | Journey Medical Corporation | Dermatology | — | To Be Discontinued | 2026-05-08 |
| Sulconazole Nitrate SolutionSolution | Journey Medical Corporation | Dermatology | — | To Be Discontinued | 2026-05-08 |
| Sulconazole Nitrate SolutionSolution | Journey Medical Corporation | Dermatology | — | To Be Discontinued | 2026-05-08 |
| Icatibant Acetate InjectionInjection | Fresenius Kabi USA, LLC | Hematology | — | To Be Discontinued | 2026-05-07 |
| Cisatracurium Besylate InjectionInjection | Hospira, Inc., a Pfizer Company | Analgesia/Addiction | — | To Be Discontinued | 2026-05-06 |
| Streptozocin Powder, For SolutionPowder, For Solution | ESTEVE PHARMACEUTICALS, S.A. | Oncology | Available | Current | 2022-07-12 |
| Cisatracurium Besylate InjectionInjection | Hospira, Inc., a Pfizer Company | Analgesia/Addiction | — | To Be Discontinued | 2026-05-06 |
| Bupivacaine Hydrochloride InjectionInjection | Kindos Pharmaceuticals Co. Ltd. | Anesthesia | Limited | Current | 2018-02-20 |
Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).